Aslan Pharmaceuticals

Targeted small molecules for cancer treatment

placeSingapore, Singapore, Singapore calendar_todayFounded 2010 groups34 employees language aslanpharma.com

Registered entities

Investor mix

17 investors on record; lead investors include MVP Capital Partners, Milestone Capital, Cenova, Accuron Technologies; 5 have since exited.

Investor typeCountShare
Venture capital529%
Private equity635%
Bank & private debt318%
Other / undisclosed318%
Coming soon